Treatment Resistant Cancers Stocks List
Related ETFs - A few ETFs which own one or more of the above listed Treatment Resistant Cancers stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.22 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.18 | |
XBI | D | SPDR S&P Biotech ETF | 0.9 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.85 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.53 |
Compare ETFs
Date | Stock | Title |
---|---|---|
May 29 | SNDX | Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket |
Related Industries:
Biotechnology
- Treatment Resistant Cancers
Treatment resistant cancers are cancers that are resistant to the standard treatments used to treat them, such as chemotherapy, radiation, and surgery. These cancers may be more difficult to treat and may require more aggressive treatments, such as targeted therapies or immunotherapies.
Popular Now
Recent Comments
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
From the Blog
Featured Articles